The study of human embryonic stem cells is a matter of intensepublic debate, primarily because derivation of such cells requiresthe destruction of human blastocysts, a procedure that somefind morally objectionable. William Hurlbut, M.D., of StanfordUniversity and a member of the President's Council on Bioethicshas recently proposed to the council an alternative way to deriveembryonic stem cells that, he argues, circumvents this objection.1The chair of the council, Leon Kass, M.D., Ph.D., favors Hurlbut'sproposal.2 We believe that it is flawed.
Hurlbut's proposal is based on the observation that mouse embryoscarrying a mutation in . . . [Full Text of this Article]
Source Information
Dr. Melton is codirector, Dr. Daley a member of the executive committee, and Dr. Jennings executive director of the Harvard Stem Cell Institute. Dr. Melton is a professor of molecular and cellular biology and an investigator of the Howard Hughes Medical Institute at Harvard University, and Dr. Daley is an associate professor of biologic chemistry and molecular pharmacology at Harvard Medical School and of pediatrics at Children's Hospital, Boston.
Scott, C. T., Reijo Pera, R. A.
(2008). The road to pluripotence: the research response to the embryonic stem cell debate. Hum Mol Genet
17: R3-R9
[Abstract][Full Text]
Findlay, J.K., Gear, M.L., Illingworth, P.J., Junk, S.M., Kay, G., Mackerras, A.H., Pope, A., Rothenfluh, H.S., Wilton, L.
(2007). Human embryo: a biological definition. Hum Reprod
22: 905-911
[Abstract][Full Text]
Alberio, R., Campbell, K. H, Johnson, A. D
(2006). Reprogramming somatic cells into stem cells.. Reproduction
132: 709-720
[Abstract][Full Text]
Mertes, H., Pennings, G., Van Steirteghem, A.
(2006). An ethical analysis of alternative methods to obtain pluripotent stem cells without destroying embryos. Hum Reprod
21: 2749-2755
[Abstract][Full Text]
Jaenisch, R., Meissner, A., Solter, D.
(2006). Politically correct human embryonic stem cells?. NEJM
354: 1208-1209
[Full Text]
Devolder, K
(2006). What's in a name? Embryos, entities, and ANTities in the stem cell debate. J. Med. Ethics
32: 43-48
[Full Text]
(2005). Recent Developments in Health Law. J Law Med Ethics
33: 384-403
Hurlbut, W. B., Melton, D. A., Daley, G. Q., Jennings, C. G.
(2005). Altered Nuclear Transfer. NEJM
352: 1153-1154
[Full Text]